Premenstrual Syndrome (PMS) is common conditions affecting women. The symptoms associated with PMS can significantly impact a womans quality of life. aims to contribute to the role of homeopathy has effectiveness in the treatment of PMS.

Phase 2

• Conditions: Health Condition 1: N943- Premenstrual tension syndrome

• Registration Number: CTRI/2024/06/069272
• Lead Sponsor: Dr Alpesh Jayswal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1 Cases suffering from PMS.

2 Age between 18 to 25 years

3 PMS Diagnosed cases with Pre-Menstrual syndrome Scale (PMSS) Score is 80 or above 80.

4 Willingness to Participate Participants who provide informed consent and are willing to comply with the study requirements, including attending scheduled visits and following the prescribed treatment regimen.

Exclusion Criteria

1 Married Women

2 Participants with Menstrual irregularities like Leucorrhoea, Dysmenorrhoea, Menorrhoea ,Metrorrhagea, PCOS

3 Medical Conditions Participants with severe medical conditions or comorbidities that may interfere with the assessment of PMS symptoms or pose a risk to their well-being.

4 Psychiatric Disorders Participants with severe psychiatric disorders, such as major depressive disorder or bipolar disorder, which may require alternative treatment approaches.

5 Hormonal Treatment Participants currently receiving or planning to initiate hormonal treatments specifically for PMS during the study period, as this may confound the evaluation of homoeopathic treatment efficacy.

6 Previous Homoeopathic Treatment Participants who have received homoeopathic treatment for PMS within a defined period (e.g 3 months) prior to the study initiation.

7 Allergy or Sensitivity Participants with known allergies or sensitivities to homoeopathic medicines or their components.

8 Substance abuse and/or dependence

9 Diagnosed or suspected cases of any malignancy

10 Patients taking Allopathic or any other systemic medicine

Study & Design

• Study Type: Interventional
• Study Design: Not specified